Enzo Biochem, Inc. (NYSE: ENZ) recently announced that it has entered into a Class Action Settlement Agreement and Release in ...
New proteins not found in nature have now been designed to counteract certain highly poisonous components of snake venom. The ...
A research team has discovered how the 'Shethna protein II' protects the nitrogen-fixing enzyme nitrogenase from damage. The oxygen sensor protein could help to make nitrogenase usable in ...
A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by ...
A research team from the Department of Chemistry at UNIST has announced that they have identified a novel pathway through ...
The current way to produce antivenoms is antiquated. Experiments in mice suggest that an artificial intelligence approach could save time and money.
G protein-coupled receptors (GPCRs), crucial for diverse physiological responses, have traditionally been investigated in ...
With regards to the average closing stock price deficiency, the Company can regain compliance at any time within the six-month period following receipt of the NYSE's non-compliance notice if, on the ...
This advancement is aimed at significantly reducing the environmental footprint of mining while improving access to essential ...
Research analysts at StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZ – Get Free Report) in a research note issued to investors on Friday. The firm set a “hold” rating on the medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback